美国FDA生物制品紫皮书数据库
(U.S. FDA Purple Book: Database of Licensed Biological Products)
商品名 申请号 产品号 BLA类型 非专利名称 剂型 给药途径 规格/剂量 产品形式 批准日期 申请人 市场状态 许可证状态 参考产品非专利名称 参考产品专利名称
125154 005 351(a) Albumin (Human) Injection Intravenous 25G/500ML Single-Use Bottle 2006/10/17 Octapharma Pharmazeutika Produktionsges.m.b.H. Rx Licensed N/A
125154 007 351(a) Albumin (Human) Injection Intravenous 12.5G/50ML Single-Use Bottle 2006/10/17 Octapharma Pharmazeutika Produktionsges.m.b.H. Rx Licensed N/A
Flulaval, Flulaval Quadrivalent 125163 001 351(a) Influenza Vaccine Injection Intramuscular 45UG/.5ML Multi-Dose Vial 2006/10/05 ID Biomedical Corporation of Quebec Rx Licensed N/A
Vectibix 125147 001 351(a) panitumumab Injection Intravenous 100MG/5ML (20MG/ML) Single-Dose Vial 2006/09/27 Amgen Inc. Rx Licensed N/A N/A
Vectibix 125147 002 351(a) panitumumab Injection Intravenous 400MG/20ML (20MG/ML) Single-Dose Vial 2006/09/27 Amgen Inc. Rx Licensed N/A N/A
Vectibix 125147 003 351(a) panitumumab Injection Intravenous 200MG/10ML (20MG/ML) Single-Dose Vial 2006/09/27 Amgen Inc. Disc Licensed N/A N/A
Tisseel 103980 002 351(a) Fibrin Sealant (Tisseel) Solution Topical 86.5 MG/ML Fibrinogen; 3000 KIU/ML Fibrinolysis Inh; 500 U/ML Thrombin Pre-Filled Syringe 2006/07/27 Baxter Healthcare Corporation Rx Licensed N/A
Elaprase 125151 001 351(a) idursulfase Injection Intravenous 6MG/3ML (2MG/ML) Single-Dose Vial 2006/07/24 Takeda Pharmaceuticals U.S.A., Inc. Rx Licensed N/A N/A
Lucentis 125156 001 351(a) ranibizumab Injection Intravitreal 10MG/ML (0.5MG/0.05ML) Single-Dose Vial 2006/06/30 Genentech, Inc. Disc* Licensed N/A N/A
Aranesp 103951 033 351(a) darbepoetin alpha Injection Intravenous, Subcutaneous 25MCG/0.42ML Autoinjector 2006/06/29 Amgen Inc. Disc Licensed N/A N/A
Aranesp 103951 034 351(a) darbepoetin alpha Injection Intravenous, Subcutaneous 40MCG/0.4ML Autoinjector 2006/06/29 Amgen Inc. Disc Licensed N/A N/A
Aranesp 103951 035 351(a) darbepoetin alpha Injection Intravenous, Subcutaneous 60MCG/0.3ML Autoinjector 2006/06/29 Amgen Inc. Disc Licensed N/A N/A
Aranesp 103951 036 351(a) darbepoetin alpha Injection Intravenous, Subcutaneous 100MCG/0.5ML Autoinjector 2006/06/29 Amgen Inc. Disc Licensed N/A N/A
Aranesp 103951 037 351(a) darbepoetin alpha Injection Intravenous, Subcutaneous 150MCG/0.3ML Autoinjector 2006/06/29 Amgen Inc. Disc Licensed N/A N/A
Aranesp 103951 038 351(a) darbepoetin alpha Injection Intravenous, Subcutaneous 200MCG/0.4ML Autoinjector 2006/06/29 Amgen Inc. Disc Licensed N/A N/A
Aranesp 103951 039 351(a) darbepoetin alpha Injection Intravenous, Subcutaneous 300MCG/0.6ML Autoinjector 2006/06/29 Amgen Inc. Disc Licensed N/A N/A
Aranesp 103951 040 351(a) darbepoetin alpha Injection Intravenous, Subcutaneous 500MCG/1ML Autoinjector 2006/06/29 Amgen Inc. Disc Licensed N/A N/A
Aranesp 103951 041 351(a) darbepoetin alpha Injection Intravenous, Subcutaneous 25MCG/0.42ML Autoinjector 2006/06/29 Amgen Inc. Disc Licensed N/A N/A
Aranesp 103951 042 351(a) darbepoetin alpha Injection Intravenous, Subcutaneous 40MCG/0.4ML Autoinjector 2006/06/29 Amgen Inc. Disc Licensed N/A N/A
Aranesp 103951 043 351(a) darbepoetin alpha Injection Intravenous, Subcutaneous 60MCG/0.3ML Autoinjector 2006/06/29 Amgen Inc. Disc Licensed N/A N/A
当前数据更新日期:2025年12月19日,更多信息请点击此处查询美国FDA药品数据库

数据库说明:

©2006-2025 DrugFuture->U.S. FDA Purple Book